Market Segment: HealthCare Specialties Niche ETFs

Evaluating Niche ETFs

Overview

ETFMG Treatments Testing and Advancements ETF

Provides direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases that focuses on the advancements in the infectious diseases at the forefront of R&D, vaccines, therapies and testing technologies.

GERM

Exchange Listing NYSE
Niche ETF – Category Innovation
Niche ETF – Market Segment Healthcare Specialties
Inception Date 6/17/20
Number of Holdings 57
Rebalancing Schedule Quarterly
Weighting Method Cap Weighted
Management Style Passive
Tactic Smart Beta
Factors Multi-factor

Additional information regarding the ETF‘s performance, pricing, NAV, trading volume, AUM, exposures and fee structure can be located by clicking on the PERFORMANCE button at the top of the page for this fund.

Prime Treatments Testing and Advancements Index

Index Summary

By clicking on the above link, you will be leaving NicheETFs.com.

Disclosure

NicheETFs.com does not promote, issuer or endorse the content of this information or guarantee it’s accuracy for the purposes of making any investment decisions. It is solely for general information purposes and should not be relied upon when making investment decisions without consulting an investment, financial or tax professional. NicheETFs.com makes no representations about the suitability of the information, products or services presented, nor of those of any issuer links. Past performance is not indicative of future results.

Innovation

EXPLORE

Impact

EXPLORE

Infrastructure

EXPLORE

AMPLIFY TRANSFORMATIONAL DATA SHARING ETF

MOTO Smart Transportation & Technology

Advertise with NicheETFs

Recent Insights

Innovation Sub-Segments

Impact Sub-Segments

Infrastructure Sub-Segments

Advertisement Space